Thromboprophylaxis in the general medical patients: making sense of the current guidelines and controversial issues

Abstract

Abstract: There is sufficient data for thromboprophylaxis in surgical patients. If we follow these guidelines for medically ill patients it would result in giving anticoagulants to a large number of patients. The guidelines are based upon prevention of asymptomatic DVT as an endpoint. The number of such patients who develop symptomatic DVT is very small. It would be worthwhile studying the risk factors for DVT in those with symptomatic DVT. We could then target thromboprophylaxis at a selected group of acutely ill medical patients who would benefit most by this intervention. 

 

Key words: Tromboprophlaxis, current guidelines, controversial issues

 

Keywords

• Tromboprophlaxis, current guidelines, controversial issues

Kaynakça

1. Geerts WH, Bergqvist D, Pineo GF, et al. American College of Chest Physicians. Prevention of venous thromboembolism:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(6 Suppl): 381S-453S
2. Stashenko GJ, Tapson VF. Prevention of venous thromboembolism in medical patients and outpatients. Nat Rev Cardiol 2009; 6: 356-63.
3. Alikhan R, Cohen AT. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No: CD003747. DOI: 10.1002/14651858.CD003747
4. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000; 160: 3415-3420.
5. Alikhan R, Cohen AT, Combe S, et al. MEDENOX Study. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004; 164: 963-968
6. Miller JA. Rational thromboprophylaxis in medical inpatients: not quite there yet. MJA 2008; 189: 504–506